New 48-week data from the Phase IIIb APEX trial (NCT04882098) show Tremfya (guselkumab; Johnson & Johnson) produces sustained inhibition of radiographic progression and improved clinical symptoms in ...

Arcutis Canada, Inc., a commercial-stage company focused on delivering meaningful innovations in immuno-dermatology, is pleased to announce that Health Canada has approved PrZORYVE® (roflumilast foam ...

A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis ...

For example, after experiencing significant fatigue walking through a stadium to attend her daughter's cheerleading competition — which required a week of recuperation afterwards — Ayesha began to ...

GEORGETOWN COUNTY, S.C. (WCSC/Gray News) - While on maternity leave, a South Carolina mother of two caught a 12-foot, 597-pound alligator, earning herself the nickname “Gator Girl.” Brittany and Matt ...